Title : Alternatives to levodopa in the initial treatment of early Parkinson's disease.

Pub. Date : 2005

PMID : 16156677






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Rasagiline is a new MAO-B inhibitor that is not broken down to amphetamine derivatives and is indicated as both monotherapy in early PD and as adjunctive therapy in PD patients with motor fluctuations. rasagiline monoamine oxidase B Homo sapiens